跳至主要内容
临床试验/JPRN-UMIN000001946
JPRN-UMIN000001946已完成未知

tility of the ART for the LOH syndrome - Clinical trial about the utility of the androgen replacement therapy (ART) in late-onset hypogonadism (LOH) syndrome

kanazawa university0 个研究点目标入组 500 人开始时间: 2011年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 90years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Prostate cancer serious complications

研究者

相似试验

已完成
4 期
ROLE OF LOW-DOSE ANTITHYROID DRUG THERAPY BEYOND THE RECOMMENDED DURATON IN THE MAINTENANCE OF EUTHYROID STATUS IN GRAVES HYPERTHYROIDISM: A RANDOMIZED CONTROLLED STUDYGraves’ hyperthyroidismGraves’ hyperthyroidism&#44once daily methimazole administration&#44induction of euthyroidism
TCTR20170705002one184
进行中(未招募)
1 期
In patients who have no more thyroid, the combination of two hormones (T3 and T4) normally secreted by thyroid will be studied, in order to evaluate their effects at the periphery. Neither doctors or patients will know if the patient is enrolled in the group treated with both hormones or in the one treated with only T4 plus a placebo.Post-surgical hypothyroidism in substitutive therapyMedDRA version: 20.0Level: LLTClassification code 10036429Term: Postsurgical hypothyroidismSystem Organ Class: 100000004863
EUCTR2016-000687-41-ITAZIENDA UNITÀ SANITARIA LOCALE DI MODENA260
已完成
2 期
A phase ll study of TS-1+L-OHP(SOX) therapy for Her2-negative advanced/metastatic gastric cancer with measurable lesions (OGSG1405)Gastric carcinoma
JPRN-UMIN000016972Osaka Gastrointestinal Cancer Chemotherapy Study Group55
Unknown
不适用
Efficacy of Luteinizing Hormone (LH) Activity in Low Responder Patients With Transdermal TestosteroneOther Complications Associated With Artificial Fertilization
NCT01291212Hospital Clinic of Barcelona104
未知
不适用
Effects of octreotide LAR treatment on QOL, clinical symptoms and endocrinological data in patients with acromegaly or pituitary gigantismacromegaly and pituitary gigantism
JPRN-C000000258Kansai Study Groups for Hypothalamic and Pituitary Diseases50